Seroepidemiology of human papillomavirus type 73: A sexually transmitted low-risk virus

International Journal of Cancer

Volumn 85, Issue 3, 2000, Pages 353-357

  Wallin, Keng Ling ^a   Van Doornum, Gerard J J ^b   Andersson Ellström, Agneta ^c   Kallings, Ingegerd ^d   Wiklund, Fredrik ^e   Hallmans, Göran ^e   Schiller, John ^f   Dillner, Joakim ^a,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c Centre for Public Health Research Karlstad   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CANCER RISK; CARCINOMA IN SITU; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SEXUAL TRANSMISSION; VIRUS TRANSMISSION; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK; SEXUALLY TRANSMITTED DISEASES, VIRAL; SWEDEN; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033987565     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000201)85:3<353::AID-IJC10>3.0.CO;2-M     Document Type: Article

References (29)

1. AF GEIJERSSTAM, V., KIBUR, M., WANG, Z., KOSKELA, P., PUKKALA, E., SCHILLER, J.T., LEHTINEN, M. and DILLNER, J., Stability over time of serum antibody levels to human papillomavirus type 16. J. infect Dis., 177, 1710-1714 (1998).
2. ANDERSSON-ELLSTRÖM, A., DILLNER, J., HAGMAR, B., SCHILLER, J., SAPP, M., FORSSMAN, L. and MILSOM, I., Comparison of development of serum antibodies to HPV 16 and HPV 33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sexu. Trans. Dis., 23, 234-238 (1996).
3. BJORGE, T. and 13 OTHERS. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res., 57, 3989-3992 (1997).
4. BOSCH, F.X., MANOS, M.M., MUNOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R., SHAH, K.V., International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796-801 (1995).
5. CARTER, J.J., KOUTSKY, L.A., WIPF, G.C., CHRISTENSEN, N.D., LEE, S.K., KUYPERS, J., KIVIAT, N. and GALLOWAY, D.A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. infect Dis., 174, 927-936 (1996).
6. CHUA, K.L., WIKLUND, F., LENNER, P., ÅNGSTRÖM, T., HALLMANS, G., BERGMAN, F. SAPP, M., SCHILLER, J., WADELL, G., HJERPE, A. and DILLNER, J., A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int. J. Cancer, 68, 54-59 (1996).
7. DE VILLIERS, E.M., Human pathogenic papillomavirus types: an update. In: Human pathogenic papillomaviruses, H. zur Hausen (ed.), pp. 1-12, Springer, Heidelberg (1994).
8. DILLNER, J., KALLINGS, I., BRIHMER, C., SIKSTRÖM, B., KOSKELA P., LEHTINEN, M., SCHILLER, J.T., SAPP, M. and MÅRDH, P.A., Seropositivities to human papillomavirus types 16, 18 or 33 and to Chlamydia Trachomatis are markers of sexual behaviour. J. infect. Dis., 173, 1394-1398 (1996).
9. DILLNER, J., KNEKT, P., SCHILLER, J.T. and HAKULINEN, T., Prospective seroepidemiological evidence thai human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. Brit. med. J., 311, 1346 (1995).
10. FRANCESCHI, S., MUNOZ, N., BOSCH, X.F., SNIJDERS, P.J. and WALBOOMERS, J.M., Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol., Biomarkers Prev., 5, 567-575 (1996).
11. HAN, C.L., QIAO, G.B., HUBBERT, N.L., LI, L.S., SUN, C.S., WANG, Y., VAN, M.X., XU, D.Z., LI, Y.G., LOWRY, D.R. and SCHILLER, J.T., Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi province, China. J. nat. Cancer Inst., 88, 1467-1471 (1996).
12. HO, G.Y.F., BIERMAN, R., BEARDSLEY, L., CHANG, C.J. and BURK, R.D., Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med., 338, 423-428 (1998).
13. KAWASHIMA, M., JABLONSKA, S., FAVRE, M., OBALEK, S., CROISSANT, O. and ORTM, G., Characterization of a new type of human papillomavirus found in a lesion of Bowen's disease of the skin. J. Virol., 57, 688-692 (1996).
14. KIRNBAUER, R., HUBBERT, N.L., WHEELER, C.M., BECKER, T.M., LOWRY, D.R. and SCHILLER, J., A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 494-499 (1994).
15. LAGERGREN, J., WANG, Z., BERGSTRÖM, R., DILLNER, J. and NYRÈN, O., Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J. nat. Cancer Inst., 91, 156-162 (1999).
16. LIPSTICH, M., Vaccination against colonizing bacteria with multiple serotypes. Proc. nat. Acad. Sci. (Wash.), 94, 6571-6576 (1997).
17. LUOSTARINEN, T. and 14 OTHERS. No excess risk of cervical carcinoma among women seropositive for both HPV 16 and HPV6/11. Int. J. Cancer, 80, 818-822 (1999).
18. MANOS, M.M., WAKDMAN, J., ZHANG, T.Y., GREER, C.E., EICHINGER, G., SCHIFFMAN, M.H. and WHEELER, C.M., Epidemiology and partial nucleotide sequence of four novel genital human papillomavirus. J. Infect. Dis., 170, 1096-1099 (1994).
19. MEYER, T., ARNDT, C.E., BECKMANN, E.R., SCHRODER, S., GISSMANN, L. and STOCKFLETH, E., Association of rare human papillomavirus types with genital premalignant and malignant lesions. J. Inject. Dis., 178, 252-255 (1998).
20. OLSEN, A.O., DILLNER, J., GJOEN, K. and MAGNUS, P., Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA. Genitourin. Med., 73, 131-135 (1997).
21. SCHILLER, J.T. and RODEN, R.B.S., Papillomavirus-like particles. Papillomavirus Rep., 6, 121-128 (1995).
22. STEWART, A-C.M., ERIKSSON, A.M., MANOS, M.M., MUNOZ, N., BOSCH, F.X., PETO, J. and WHEELER, C.M., Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol., 70, 3127-3136 (1996).
23. SYRJÄNEN, K.J., Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Archiv. Geschwulstforsch., 52, 283-292 (1982).
24. VAN DOORNUM, G., PRINS, M., ANDERSSON-ELLSTROdie;M, A. and DILLNER, J., Immunoglobulin A, G and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18 and 18 after newly acquired infection. Sexu. transm. Infect., 74, 354-360 (1998).
25. VAN DOORNUM, G.J.J., HOOYKAAS, C., JUFFERMANS, L.H.J., VAN DER LANS, S.M.G.A., VAN DER LINDEN, M.M.D., COUTINHO, R.A. and QUINT, W.G.V., Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners. J. med. Virol., 37, 13-21 (1992).
26. VOLTER, C., HE, Y., DELIUS, H., ROY-BURMAN, A., GREENSPAN, J.S., GREENSPAN, D. and DE VILLIERS, E.M., Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int. J. Cancer, 66, 453-456 (1996).
27. WEST, A.B., SOLOWAY, G.N., LIZARRAGA, G., TYRRELL, L. and LONGLEY, J.B., Type 73 human papillomavirus in esophageal squamous cell carcinoma: a novel association. Cancer, 77, 2440-2444 (1996).
28. WIKSTRÖM, A., VAN DOORNUM, G.J., KIRNBAUER, R., QUINT, W.G. and DILLNER, J., Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection. J. med. Virol., 46, 368-374 (1995a).
29. WIKSTRÖM, A., VAN DOORNUM, G.J.J., QUINT, W.G.V., SCHILLER, J.T. and DILLNER, J., Identification of human papillomavirus seroconversions. J. gen. Virol., 76, 529-539 (1995b).